| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |